Spiky Gold Nanoparticles, a Nanoscale Approach to Enhanced Ex Vivo T-Cell Activation
- 30 July 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (32) , 21554-21564
Abstract
While existing synthetic technologies for ex vivo T-cell activation face challenges like suboptimal expansion rates and low effectiveness, artificial antigen-presenting cells (aAPCs) hold great promise for enhanced T-cell based therapies. In particular, gold nanoparticles (AuNPs), known for their biocompatibility, ease of synthesis, and versatile surface chemistry, are strong candidates for use as nanoscale aAPCs. In this study, we developed spiky AuNPs with branched geometries to present activating ligands to primary human T-cells. The special structure of spiky AuNPs enhances biomolecule loading capacity and significantly improves T-cell activation through multivalent binding of costimulatory ligands and receptors. Our spiky AuNPs outperform existing systems including Dynabeads and soluble activators by promoting greater polyclonal expansion of T-cells, boosting sustained cytokine production, and generating highly functional T-cells with reduced exhaustion. In addition, spiky AuNPs effectively activate and expand CD19 CAR-T cells while demonstrating increased in vitro cytotoxicity against target cells using fewer effector cells than Dynabeads. This study underscores the potential of spiky AuNPs as a powerful tool, bringing new opportunities to adoptive cell therapy applications.Keywords
Funding Information
- National Institutes of Health (610-4011400-60065204)
- National Institute of General Medical Sciences (2R01GM131421-05)
This publication has 54 references indexed in Scilit:
- Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer ImmunotherapyAdvanced Materials, 2024
- Engineering Near‐Infrared Plasmonic Spiky Gold Nanostructures for Highly Efficient Surface‐Enhanced Raman Spectroscopy‐Guided Cancer Hyperthermia TherapyAdvanced Functional Materials, 2023
- Differential Macrophage Responses to Gold Nanostars and Their Implication for Cancer ImmunotherapyAdvanced Therapeutics, 2022
- Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapyBiomaterials, 2021
- A novel dendritic cell-based direct ex vivo assay for detection and enumeration of circulating antigen-specific human T cellsCytotechnology, 2018
- CD69: from activation marker to metabolic gatekeeperEuropean Journal of Immunology, 2017
- Gold nanoparticle‐mediated photothermal therapy: applications and opportunities for multimodal cancer treatmentWIREs Nanomedicine and Nanobiotechnology, 2017
- Biodegradable Nanoellipsoidal Artificial Antigen Presenting Cells for Antigen Specific T‐Cell ActivationSmall, 2015
- Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cellsBiomaterials, 2014
- Surface markers of lymphocyte activation and markers of cell proliferationClinica Chimica Acta, 2012